You can search for open trials at clinicaltrials.gov using the search terms retatrutide or LY3437943. General eligibility criteria for most TRIUMPH trials include: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related condition No use of other weight loss medications in the prior 90 days No personal or family history of medullary thyroid carcinoma or MEN-2 No recent pancreatitis, heart attack, or stroke (within the prior 90 days) No prior bariatric surgery A note on online sales: The FDA has issued warnings about illegal websites selling substances that claim to be retatrutide
Written informed consent to participate in this study was provided by the participants or their legal guardian/next of kin
These preliminary findings suggest potential benefits worthy of further investigation with optimized dosing protocols
Tri-Amino Blend (L-Arginine, L-Citrulline, L-Ornithine): Improves blood flow and nutrient delivery for that fresh, radiant glow
CoQ10 is an integral component of all cellular mitochondrial respiratory chains, participating in the processes of electron transfer and oxidative phosphorylation (Lpez-Snchez et al., 2025)
Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence